Discovery of Novel and Selective Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease through Comparative Structure-Based Virtual Screening-Reference-Cited by-同舟云学术

Discovery of Novel and Selective Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease through Comparative Structure-Based Virtual Screening

Published:2017-05-15 Issue:6 Volume:57 Page:1474-1487
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Tian Sheng¹,Wang Xu¹,Li Linlang¹,Zhang Xiaohu¹,Li Youyong²^ORCID,Zhu Feng³,Hou Tingjun³^ORCID,Zhen Xuechu¹

Affiliation:

1. Jiangsu Key Laboratory of Translational Research and Therapy for Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China

2. Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu 215123, China

3. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China

Funder

Ministry of Education of the People's Republic of China

Ministry of Science and Technology of the People's Republic of China

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Priority Academic Program Development of the Jiangsu Higher Education Institutes

Jiangsu Key laboratory for Translational Research for Neuropsychiatric Diseases, Soochow University

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.7b00188

Reference62 articles.

1. Movement disorders: advances in 2015

2. Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

3. Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

4. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

5. l-Stepholidine reduced l-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor;Journal of Medicinal Chemistry;2024-07-29

3. Identification of 3-aryl-5-methyl-isoxazole-4-carboxamide derivatives and analogs as novel HIF-2α agonists through docking-based virtual screening and structural modification;European Journal of Medicinal Chemistry;2024-03

4. Computational Workflow for Refining AlphaFold Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive Human Adenosine A₃ Receptor;The Journal of Physical Chemistry B;2024-01-18

5. Discovery of novel A2AR antagonists through deep learning-based virtual screening;Artificial Intelligence in the Life Sciences;2023-12